HIND vs JAZZ · rev $58.5K vs P/E 1988, rev $2.28B
Vyome Holdings, Inc. (HIND) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Vyome Holdings, Inc. (HIND) is a biotechnology company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported HIND revenue for 2026-06-30 was $58.5K. Net income was -$1.6M. Revenue was up 85.3% from 2026-03-31 to 2026-06-30. HIND currently screens at market cap $16.1M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
HIND currently screens at market cap $16.1M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the HIND and JAZZ stock pages for the full models.
Not investment advice.